Euronet Worldwide Inc. (NASDAQ:EEFT) reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an earnings per share (EPS) of $2.08, slightly above the forecast of $2.05. The ...
GOMEKLI™ is an oral, small molecule MEK inhibitor approved in the United States for the treatment of adult and pediatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback